Leading Autoinjector Manufacturers

Published: July 2024


Self-injection devices (primarily autoinjectors) are revolutionizing the management of chronic diseases, by empowering patients with precise and convenient drug dosing. We analyzed more than 50 companies that are actively engaged in manufacturing around 150 autoinjectors. In this article, discover the top 5 autoinjector manufacturers.

The global rise in chronic diseases, such as diabetes, multiple sclerosis, rheumatoid arthritis and severe allergies, has driven a pressing requirement for a more efficient, innovative and user-friendly drug delivery systems. As a result, the medical industry has made significant efforts in developing novel drug delivery devices, including autoinjectors. These devices deliver a particular dose of a therapeutic substance with simple push of a button; in addition, they simplify the administration of injectable drugs, offer precise dosing and eliminate the dependence on healthcare providers for drug injection. 

Smart autoinjectors comprise of audio and visual feedback system, that guides the users during the injection process, enhances safety and improves patient experience, thereby contributing to effective management of health conditions. In addition, improved ergonomic designs allow convenient handling of the device by patients with limited dexterity. Notably, large volume autoinjectors are a novel evolution in the drug delivery devices field, designed to inject higher doses of drugs in a single time.

It is worth mentioning that the autoinjectors market is anticipated to witness substantial growth in the coming years, owing to the growing biologics market (requiring parenteral administration), shift towards self-injection of drugs by patients, expanding use of autoinjectors in new therapeutic areas and development of connected auto-injector (with features such as bluetooth and wireless connectivity). 

Roots Analysis has conducted an exhaustive study on Autoinjectors Market featuring the current market landscape of autoinjector manufacturers and future opportunity associated with the autoinjectors market, over the forecast period 2023-2035.

Table of Contents

Below, we have listed (in alphabetical order), the top 5 autoinjector manufacturers:

  1. Owen Mumford
  2. SHL Medical
  3. Ypsomed
  4. Elcam Medical
  5. Union Medico

Interested in exploring all 50+ autoinjector manufacturers across various regions?

In this Article, Discover the Details on Top 5 Autoinjector Manufacturers

This article highlights the top 5 players to watch out for in this industry. These companies were chosen based on the number of autoinjectors being manufactured by them (having more than eight autoinjectors in their product portfolio). It is essential to note that the selection of top players can differ substantially according to the defined criteria.

Owen Mumford has Extensive Experience in Designing Advanced Self-injection Devices, with its First Autoinjector being Launched in 1986

Cortex Discovery - Deep Learning

Owen Mumford is a privately-held company that designs and manufactures innovative medical devices to enhance patient care and healthcare outcomes. Owing to its technical expertise, sophisticated facilities and robust quality management system, the company offers innovative solutions, including autoinjectors, blood sampling devices, pen needles and safety lancets. In April 2023, the company (along with Stevanato) was awarded “Red Dot” for the design of their single use autoinjector, namely Aidaptus. Further, it claims to work closely with its clients, partners and stakeholders in order to understand their requirements and develop customized solutions.

Autoinjectors Portfolio:

The table below presents Owen Mumford auto injector:

Autoinjector Status of Development Usability    Type of Dose Delivered   Actuation Mechanism  
LyoTwist Trio Commercialized Disposable Autoinjector Variable Automatic
LyoTwist Trio S Commercialized Reusable Autoinjector Fixed Automatic
LyoTwist Vario Commercialized Reusable Autoinjector Fixed Automatic
LyoTwist Vario S Commercialized Disposable Autoinjector Fixed Automatic
YpsoMate® Commercialized Reusable Autoinjector Fixed Automatic
YpsoMate 2.25 Commercialized Disposable Autoinjector Fixed Automatic
YpsoMate 2.25 Pro Commercialized Disposable Autoinjector Fixed Automatic
YpsoMate 5.5 Commercialized Disposable Autoinjector
Reusable Autoinjector
Fixed Automatic
YpsoMate On Commercialized Disposable Autoinjector Fixed
Variable
Automatic
YpsoMate Zero Commercialized Disposable Autoinjector Fixed Automatic
VarioJect Auto-Injector Commercialized Disposable Autoinjector Fixed
Variable
Automatic

Recent Developments: 

  • In November 2023, Owen Mumford participated in the WAND Annual Conference, held in Wales, UK. 
  • In November 2023, the company participated in the NAMDET conference, held in Wales, UK. 
  • In November 2023, the company presented at PDA Aseptic Processing of Biopharmaceuticals Conference, held in Incheon, Korea.
  • In May 2022, the company entered into a collaboration with Stevanato Group to manufacture single use Aidaptus® autoinjector, thereby giving access of new customers to the former company and influencing their device decisions at the first opportunity.

Further information related to the autoinjectors portfolio of Owen Mumford and other autoinjector manufacturers is available in the full report.

With the Development of Convenient and Safe Autoinjectors, SHL Medical Focuses on Offering Patient-friendly Treatment Options

Cortex Discovery - Deep Learning

SHL Medical is a privately-owned company, dedicated to the design, development and manufacturing of pen injectors, autoinjectors and innovative solutions for the delivery of large volume and high viscosity drugs. Leveraging its comprehensive knowledge, the company claims to have supported the development of over 40 marketed drug device combination products. In addition, the firm offers contract manufacturing and engineering services for products, including laboratory handling equipment, neurosurgical devices and industrial equipment. According to the company website, it operates across different locations, including Sweden, Switzerland, Taiwan and the US; specifically, in Taiwan, it has six manufacturing units. The company states to be certified as per the ISO international quality management system (ISO 14001 and ISO 45001).

Autoinjectors Portfolio:
The table below presents the autoinjectors manufactured by SHL Medical:

Autoinjector Status of Development Usability    Type of Dose Delivered   Actuation Mechanism  
Amber® Commercialized Disposable Autoinjector Fixed Automatic
Bertha® Commercialized Disposable Autoinjector Fixed Automatic
DAI® Commercialized Disposable Autoinjector Fixed Automatic
DAI 2® Commercialized Disposable Autoinjector Fixed Automatic
Maggie® Commercialized Disposable Autoinjector Fixed Automatic
Molly ® Commercialized Disposable Autoinjector Fixed Manual
Molly 2.25 Auto-Injector Commercialized Disposable Autoinjector Fixed Manual
Molly Flexible Needle Shield (FNS) Commercialized Disposable Autoinjector Fixed Manual
Molly Rigid Needle Shield (RNS) Commercialized Disposable Autoinjector Fixed Manual
SDI MIX® + NIT® Commercialized Disposable Autoinjector Fixed Manual
VSDI® + NIT ® Commercialized Disposable Autoinjector Variable Manual
Maggie® 5.0 Under Development Disposable Autoinjector Fixed Automatic

Recent Developments: 

  • In February 2024, SHL Medical participated in the SCbio 2024, held in South Carolina, US. 
  • In January 2024, the company announced the acquisition of Superior Tooling to further strengthen its in-house manufacturing capabilities.
  • In January 2024, the company entered into an agreement with SteriPack Group to establish assembly services at the latter company’s facility in Poland. 
  • In January 2024, the company entered into an agreement with FUJIFILM Diosynth Biotechnologies to use latter company’s final assembly services for the former company’s Molly autoinjector. 
  • In January 2024, the company participated in the Pharmapack Europe, held in Paris, France.

Further information related to the autoinjectors portfolio of SHL Medical and other autoinjector manufacturers is available in the full report.

Ypsomed, Delivering Antibodies and Peptides Through its Autoinjectors (integrated with audible and visual feedback mechanism), Predominantly Targets Rheumatoid Arthritis and Diabetes

Cortex Discovery - Deep Learning

Ypsomed is a specialty pharmaceutical company focusing on the development and manufacturing of self-administration devices (including injection and infusion systems). The company has two business segments, namely Ypsomed Diabetes Care (operating under the brand, mylife Diabetescare) and Ypsomed Delivery Systems. Through mylife Diabetescare, it offers blood glucose monitoring, insulin pumps and safety pen needles directly to patients or with clinics and retailers as intermediates. In addition, through Ypsomed Delivery, the company offers self-injection devices such as autoinjectors, pen systems and wearable injectors. Notably, it operates through a network of manufacturing sites, subsidiaries and distributors located in more than 50 countries. According to the company website, it has signed 26 new projects in order to expand its product portfolio and support the needs of patients.

Autoinjectors Portfolio:
The table below presents the autoinjectors manufactured by Ypsomed:

Autoinjector Status of Development Usability    Type of Dose Delivered   Actuation Mechanism  
Aidaptus® Commercialized Disposable Autoinjector Variable Automatic
Autoject 2 Commercialized Reusable Autoinjector Fixed Automatic
Autoject® 2 Commercialized Reusable Autoinjector Fixed Automatic
UniSafe® 2.25 Commercialized Disposable Autoinjector Fixed Automatic
Autoject® EI Commercialized Reusable Autoinjector Fixed Automatic
Autoject Flex Commercialized Disposable Autoinjector Fixed Automatic
Autoject Micro Commercialized Disposable Autoinjector Fixed Automatic
Autoject Mini Commercialized Disposable Autoinjector
Reusable Autoinjector
Fixed Automatic
Autoject Multi Commercialized Disposable Autoinjector Fixed
Variable
Automatic
Autoject Uni Commercialized Disposable Autoinjector Fixed Automatic
Autoject Visco Commercialized Disposable Autoinjector Fixed
Variable
Automatic
UniSafe® Reusable Under Development Reusable Autoinjector Fixed Manual
UniSafe® 1mL Connected Under Development Reusable Autoinjector Fixed Manual

Recent Developments: 

  • In September 2023, the company entered into an agreement with Novo Nordisk to use the variants of former company’s autoinjectors for the delivery of drugs developed by latter company.
  • In July 2023, the company signed partnership with S3 Connected Health to integrate the latter’s technology into the former’s devices to expand its digital health offering.
  • In June 2023, the company entered into an agreement with Interface Analysis Associates to support Human Factors (HF) services in order to enhance their device customization process
  • In June 2023, the company set up a manufacturing facility for infusion sets, pens and autoinjectors, located in Schwerin, Germany; the expansion involved an investment of EUR 20 million.

Further information related to the autoinjectors portfolio of Ypsomed and other autoinjector manufacturers is available in the full report.

Elcam Medical’s Autoinjectors Deliver Medium Viscosity Medications Primarily via Subcutaneous Route, Outside the Clinical Environment

Cortex Discovery - Deep Learning

Elcam Medical offers disposable stopcocks (focusing on fluid control), medical devices (focusing on patient monitoring, medication delivery and interventional procedures) and accessories (focusing on intravenous therapy and bloodline). The firm offers a comprehensive range of solutions for various medical areas, including anesthesia, dialysis, intensive care, interventional cardiology, oncology and radiology. Through its Elcam Drug Delivery Devices division, the company develops and manufactures autoinjectors, on-body injectors, pen devices and patch pumps (suitable for conventional, biological and biosimilar drugs). Further, the company claims that its complete manufacturing process (from tooling to packing) is certified by the ISO quality management system and is compliant with occupational health and safety management systems (OHSMS).

Autoinjectors Portfolio:
The table below presents the autoinjectors manufactured by Elcam Medical:

Autoinjector Status of Development Usability    Type of Dose Delivered   Actuation Mechanism  
Flexi-Q CAI 100 Commercialized Disposable Autoinjector Fixed Automatic
Flexi-Q CAI 100 Commercialized Disposable Autoinjector Fixed Automatic
Flexi-Q DV  Commercialized Disposable Autoinjector Variable
Fixed
Automatic
Flexi-Q DV  Commercialized Disposable Autoinjector Variable
Fixed
Automatic
Flexi-Q EAI 100 Commercialized Disposable Autoinjector Fixed Automatic
Flexi-Q EAI 100 Commercialized Disposable Autoinjector Fixed Automatic
Flexi-Q eMU-P  Commercialized Reusable Autoinjector Variable
Fixed
Automatic
Flexi-Q HV Commercialized Disposable Autoinjector Fixed Automatic
Flexi-Q Mmu Commercialized Reusable Autoinjector Fixed Automatic
Flexi-Q PFS  Commercialized Disposable Autoinjector Fixed Automatic
Flexi-Q eMU-C  Under Development Reusable Autoinjector Variable Automatic

Recent Developments: 

  • In February 2024, Elcam Medical participated in MD&M West Conference, held in California, US
  • In January 2024, the company participated in Pharmapack Conference, held in Paris, France.

Further information related to the autoinjectors portfolio of Elcam Medical and other autoinjector manufacturers is available in the full report.

Through its Autoinjectors, Union Medico Offers Needle-shield Protection and Smart Click System; the Firm Effectively Focuses on Reducing Drug Wastage and Enhancing Medicine Life Span

Cortex Discovery - Deep Learning

Union Medico is engaged in the development and manufacturing of injectable drug delivery systems. The company claims to have patented a technology that can be adapted to different injectable drugs; further, it offers various advantages, including stable needle penetration, controlled drug delivery, high drug efficacy and less side effects. Further, it is compliant with the regulations of different governing bodies, such as FDA, Health Canada, CiToxLab and Medical Valley Alliance.

Autoinjectors Portfolio:
The table below presents the autoinjectors manufactured by Union Medico:

Autoinjector Status of Development Usability    Type of Dose Delivered   Actuation Mechanism  
90°/S Commercialized Disposable Autoinjector Variable Manual
90°/XL Commercialized Disposable Autoinjector Variable Manual
90°/XL Commercialized Reusable Autoinjector Variable Manual
90° Exclusive™ Commercialized Disposable Autoinjector Variable Manual
Semi 45°s Commercialized Reusable Autoinjector Variable Manual
Semi 45°M Commercialized Disposable Autoinjector Variable Manual
Semi 90°/M Commercialized Disposable Autoinjector Variable Manual
90° Super Grip™ Under Development Reusable Autoinjector Variable Manual
Semi 45°R Under Development Reusable Autoinjector Variable Manual

Recent Developments: 
Union Medico, a drug delivery devices manufacturer, strives to cater to the needs of various pharmaceutical and life science industries, through enhanced product quality. Owing to its strong research and development expertise, the company focuses on developing advanced injection devices. It is worth mentioning that the company’s patented technology can be integrated with their all-injection devices.

Further information related to the autoinjectors portfolio of Union Medico and other autoinjector manufacturers is available in the full report.

What About the Other Autoinjector Manufacturers?

The above presentation features the top 5 autoinjector manufacturers selected from a pool of over 50 firms that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.

Sources:
1.    “Owen Mumford announce an exciting collaboration with multinational drug container manufacturer Stevanato Group”
https://www.owenmumford.com/us/owen-mumford-announce-exciting-collaboration-multinational-drug-container-manufacturer-stevanato

2.    “SHL Medical acquires 100% of the shares in Swiss company LCA Automation”
https://www.shl-medical.com/shl-medical-acquires-lca-automation/

3.    “Ypsomed concludes a long-term supply agreement for large quantities of autoinjectors”
https://www.ypsomed.com/en/media/details/ypsomed-concludes-a-long-term-supply-agreement-for-large-quantities-of-autoinjectors.html